DENTSPLY SIRONA (NASDAQ:XRAY) Issues Q3 2024 Earnings Guidance

DENTSPLY SIRONA (NASDAQ:XRAY) issued an update on its third quarter 2024 earnings guidance on Thursday morning. The company provided EPS guidance of 0.490-0.510 for the period, compared to the consensus EPS estimate of 0.470. The company issued revenue guidance of $951.0 million-$951.0 million, compared to the consensus revenue estimate of $937.9 million. DENTSPLY SIRONA also updated its Q3 guidance to $0.49-0.51 EPS.

DENTSPLY SIRONA Price Performance

Shares of XRAY stock traded down $1.10 during midday trading on Friday, reaching $23.31. 3,688,608 shares of the company were exchanged, compared to its average volume of 2,965,741. The company’s 50 day moving average price is $25.22 and its two-hundred day moving average price is $26.52. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.87 and a current ratio of 1.33. The company has a market cap of $4.73 billion, a P/E ratio of -27.10, a PEG ratio of 1.17 and a beta of 1.00. DENTSPLY SIRONA has a 12 month low of $22.85 and a 12 month high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing the consensus estimate of $0.50 by ($0.01). The firm had revenue of $984.00 million during the quarter, compared to analyst estimates of $993.61 million. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The company’s quarterly revenue was down 4.3% compared to the same quarter last year. During the same quarter last year, the company earned $0.51 EPS. On average, sell-side analysts expect that DENTSPLY SIRONA will post 1.98 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 11th. Stockholders of record on Friday, September 27th were paid a $0.16 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $0.64 annualized dividend and a dividend yield of 2.75%. DENTSPLY SIRONA’s dividend payout ratio is currently -74.42%.

Wall Street Analysts Forecast Growth

XRAY has been the topic of several recent research reports. Barrington Research restated an “outperform” rating and issued a $36.00 price target on shares of DENTSPLY SIRONA in a research report on Friday, September 20th. Stifel Nicolaus decreased their target price on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a report on Thursday, July 18th. Robert W. Baird reduced their target price on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a report on Monday, July 22nd. Needham & Company LLC decreased their price target on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a research report on Friday. Finally, Evercore ISI cut their price objective on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. Five investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $32.67.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.